Cargando…
Using a new diagnostic tool to predict lymph node metastasis in advanced epithelial ovarian cancer leads to simple lymphadenectomy decision rules: A multicentre study from the FRANCOGYN group
OBJECTIVE: The aim of this study was to develop a new diagnostic tool to predict lymph node metastasis (LNM) in patients with advanced epithelial ovarian cancer undergoing primary cytoreductive surgery. MATERIALS AND METHOD: The FRANCOGYN group’s multicenter retrospective ovarian cancer cohort furni...
Autores principales: | Mimoun, Camille, Paoletti, Xavier, Gaillard, Thomas, Crestani, Adrien, Benifla, Jean-Louis, Mezzadri, Matthieu, Bendifallah, Sofiane, Touboul, Cyril, Bricou, Alexandre, Dabi, Yohann, Canlorbe, Geoffroy, Kerbage, Yohan, Lavoué, Vincent, Ouldamer, Lobna, Lecointre, Lise, Coutant, Charles, Fauconnier, Arnaud, Rouzier, Roman, Huchon, Cyrille |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8525770/ https://www.ncbi.nlm.nih.gov/pubmed/34665839 http://dx.doi.org/10.1371/journal.pone.0258783 |
Ejemplares similares
-
Recommendations for the surgical management of gynecological cancers during the COVID-19 pandemic - FRANCOGYN group for the CNGOF()
por: Akladios, Cherif, et al.
Publicado: (2020) -
Therapeutic value of surgical paraaortic staging in locally advanced cervical cancer: a multicenter cohort analysis from the FRANCOGYN study group
por: Dabi, Yohann, et al.
Publicado: (2018) -
Impact on Prognosis of the Surgical Route, Laparoscopy or Laparotomy, for the Surgical Staging of Early Stage Ovarian Cancer—A Study from the FRANCOGYN Group
por: Merlier, Margaux, et al.
Publicado: (2020) -
Does Time-to-Chemotherapy after Primary Complete Macroscopic Cytoreductive Surgery Influence Prognosis for Patients with Epithelial Ovarian Cancer? A Study of the FRANCOGYN Group
por: Rocher, Grégoire, et al.
Publicado: (2021) -
Impact of Lymphadenectomy on Survival of Patients with Serous Advanced Ovarian Cancer After Neoadjuvant Chemotherapy: A French National Multicenter Study (FRANCOGYN)
por: Bund, Virginie, et al.
Publicado: (2020)